SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 10-Q



              [X] QUARTERLY REPORT UNDER SECTION 13 or 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 2003
                           Commission File No. 2-70197

                              OCEAN BIO-CHEM, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


            Florida                                           59-1564329
------------------------------                       ---------------------------
(State or other jurisdiction of                           I.R.S. Employer
incorporation or organization)                           Identification No.)


4041 S. W. 47 Avenue, Fort Lauderdale, Florida                          33314
--------------------------------------------------------------------------------
(Address of principal executive offices)                              (Zip Code)

Registrant's telephone number, including area code - (954) 587-6280

     Indicate  by check mark  whether the  Registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

          YES [ X  ]                                      NO [     ]

     Indicate by check mark whether the Registrant ia an  Accelerated  Filer (as
defined in Rule 12b-2 of the Exchange Act).

          YES [   ]                                       NO [  X  ]

     Indicate the number of shares  outstanding of each of the Issuer's  classes
of common stock, as of the latest practicable date.


            $.01 Par Value Common Stock 10,000,000 shares authorized;
             4,960,843 issued and outstanding at September 30, 2003.



<PAGE>



                         OCEAN BIO-CHEM AND SUBSIDIARIES

                                      INDEX


Description                                                               Page
                                                                          ----
Part I:

 Item 1. -  Financial Statements:

     Consolidated balance sheets as of September 30, 2003
       and December 31, 2002                                                3
     Consolidated statements of operations for the three and
       nine months ended September 30, 2003 and 2002                        4

     Consolidated statements of changes in shareholders'
       equity for the nine months ended September 30, 2003
       And 2002                                                             5

     Consolidated statements of cash flows for the nine months
       Ended September 30, 2003 and 2002                                    6

 Item 2. -  Management's Discussion and Analysis of Financial
            Condition and Results of Operations                            7-8

Part II:

 Item 1. - Legal Proceedings                                                9
 Item 2. - Changes in Securities                                            9
 Item 3. - Defaults upon Senior Securities                                  9
 Item 4. - Submission of Matters to Vote by Security Holders                9
 Item 5. - Other information                                                9
 Item 6. - Exhibits and Reports on Form 8-K                                 9


Signatures                                                                  9

Certifications                                                            10-13

















                                        2


<PAGE>
                         Part I - Financial Information

Item I. Financial Statements

                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS

                                     ASSETS
<TABLE>
<CAPTION>
                                                              SEPTEMBER 30,       DECEMBER 31,
                                                                  2003               2002
                                                             --------------      -------------
                                                              (Unaudited)
<S>                                                          <C>                 <C>
Current assets:
   Cash                                                      $      240,025      $   1,093,826
   Trade accounts receivable net of allowances for
     doubtful accounts of approximately $ 81,500 and
     $ 200,700 at September 30, and December 31, 2002,
     respectively                                                 4,374,276          3,190,357
Inventories                                                       6,151,101          4,541,150
   Prepaid expenses and other current assets                        216,957            129,622
   Recoverable income taxes                                           -                240,000
                                                             --------------      -------------
       Total current assets                                      10,982,359          9,194,955
                                                             --------------      -------------

Property, plant and equipment, net                                7,578,052          6,977,003
                                                             --------------      -------------
Other assets:
   Funds held in escrow for equipment, net                          203,320          1,161,194
   Trademarks, trade names and patents, net
     of accumulated amortization                                    330,439            330,439
   Deposits and other assets                                        306,468            374,371
   Due from affiliated companies, net                               314,234            612,275
                                                             --------------      -------------
       Total other assets                                         1,154,461          2,478,279
                                                             --------------      -------------

      Total assets                                           $   19,714,872      $  18,650,237
                                                             ==============      =============

                      LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
   Accounts payable - trade                                  $    2,517,337      $   1,833,895
   Note payable - bank                                            4,750,000          4,250,000
   Current portion of long-term debt                                557,022            601,766
   Accrued expenses payable                                         189,953            296,422
                                                             --------------      -------------
       Total current liabilities                                  8,014,312          6,982,083
                                                             --------------      -------------

Deferred income taxes payable                                       253,139            183,139
                                                             --------------      -------------

Long term debt, less current portion                              6,172,930          6,562,093
                                                             --------------      -------------

Shareholders' equity:
   Common stock - $.01 par value 10,000,000
     shares authorized, 4,960,843 and 4,805,843
     issued and outstanding at September 30, 2003
     and December 31, 2002, respectively                             49,608             48,058
   Additional paid-in capital                                     4,409,829          4,341,629
   Foreign currency translation adjustment                   (      254,571)     (     303,575)
   Retained earnings                                              1,077,820            845,005
                                                             --------------      -------------
                                                                  5,282,686          4,931,117
   Less cost of common stock in treasury,
     7,519 shares at September 30, 2003
     and December 31, 2002, respectively                     (        8,195)     (       8,195)
                                                             --------------      -------------
                                                                  5,274,491          4,922,922
                                                             --------------      -------------

Total liabilities and shareholders' equity                   $   19,714,872      $  18,650,237
                                                             ==============      =============
</TABLE>
                                        3

<PAGE>
                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)
<TABLE>
<CAPTION>

                                               For the three months                 For the nine months
                                                ended September 30,                 ended September 30,
                                               2003            2002                2003            2002
                                               ----            ----                ----            ----
<S>                                          <C>            <C>                <C>              <C>
Gross sales                                  $7,147,944     $ 7,658,158        $15,835,996      $16,587,467
Allowances                                      715,394         810,807          1,421,928        1,557,210
                                             ----------     -----------        -----------      -----------

Net sales                                     6,432,550       6,847,351         14,414,068       15,030,257
Cost of goods sold                            4,675,359       5,489,046         10,851,142       11,469,122
                                             ----------     -----------        -----------      -----------

Gross profit                                  1,757,191      1,358,305           3,562,926        3,561,135
                                             ----------   -------------        -----------      -----------

Cost and expenses:
   Advertising and promotion                    313,256         173,128            640,580          553,893
   Selling and administrative                   754,069         718,497          2,361,976        2,060,652
   Interest expense                              70,642          95,270            218,333          265,431
                                             ----------     -----------        -----------      -----------
     Total costs and expenses                 1,137,967         986,895          3,220,889        2,879,976
                                             ----------     -----------        -----------      -----------

Income from operations                          619,224         371,410            342,037          681,159

Interest income                                   7,544           3,061             10,778            3,126
                                             ----------     -----------        -----------      -----------

Income before provision
   For income taxes                             626,768         374,471            352,815          684,285

Provision for income taxes                      120,000         118,700            120,000          232,700
                                             ----------     -----------        -----------      -----------

Net income                                      506,768         255,771            232,815          451,585

Other comprehensive income, net
  of income taxes:
      Foreign currency
      translation adjustment                 (      708)    (    25,247)            49,004      (    31,099)
                                             ----------     -----------        -----------      -----------

Comprehensive income                         $  506,060     $   230,524        $   281,819      $   420,486
                                             ==========     ===========        ===========      ===========

Earnings per common share                    $   .10        $    .05           $    .05         $    .10
                                             ==========     ===========        ===========      ===========





     Earnings per share for the nine and three months ended  September  30, 2003
were  calculated  on the basis of 4,866,605  weighted  average  shares of common
stock  outstanding.  For the nine and three  months  ended  September  30, 2002,
earnings per share were calculated  using 4,318,370  weighted  average shares of
common  stock  outstanding.

     The company has adopted Statement of Financial Accounting Standards No. 130
which requires items of  comprehensive  income to be stated as part of the basic
financial  statements.  The only items of comprehensive income of the Registrant
which  are  reflected  in the  accompanying  financial  statements  are  foreign
currency translation adjustments.

</TABLE>


                                        4


<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                        CONSOLIDATED STATEMENT OF CHANGES
                             IN SHAREHOLDERS' EQUITY
                            FOR THE NINE MONTHS ENDED
                           SEPTEMBER 30, 2003 AND 2002
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                             Additional      Foreign
                               Common stock                   paid-in        currency        Retained     Treasury
                                 Shares        Amount         capital       adjustment       earnings      stock          Total
                               ---------     ----------     -----------     ----------      ---------     ----------    ------------
<S>                            <C>           <C>            <C>             <C>             <C>           <C>           <C>
January 1,
   2003                        4,805,843     $   48,058     $ 4,341,629     ($ 303,575)     $  845,005    ($  8,195)    $  4,922,922


Net Income                                                                                     232,815                        32,815

Issuances of stock               155,000          1,550          68,200                                                       69,750

Foreign currency
   translation
   adjustment                                                                   49,004                                        49,004
                               ---------     ----------     -----------     -----------     ----------    ----------    ------------

September 30,
   2003                        4,960,843     $   49,608     $ 4,409,829     ($ 254,571)     $1,077,820    ($  8,195)    $  5,274,491
                               =========     ==========     ===========     ===========     ==========    ==========    ============


January 1,
   2002                        4,239,889     $   42,399     $ 3,755,219     ($ 262,933)     $1,234,832    ($  8,195)    $  4,761,322


Net income                                                                                     451,585                       451,585

Issuances of stock               129,000          1,290          66,435                                                       67,725

Foreign currency
   translation
   adjustment                                                               (   31,099)                                       31,099
                               ---------     ----------     -----------     ----------      ----------    ----------    ------------


September 30,
   2002                        4,368,889     $   43,689     $ 3,821,654     ($ 294,032)     $1,686,417    ($  8,195)    $  5,249,533
                               =========     ==========     ===========     ===========     ==========    =========     ============






</TABLE>








                                        5


<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                     FOR THE NINE MONTHS ENDED SEPTEMBER 30,
                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                                                2003           2002
                                                            -----------     -----------
<S>                                                         <C>             <C>
Cash flows provided by operating activities:
Net Income                                                  $   232,815     $   451,585
Adjustments to reconcile net income
   to net cash provided by operations:
         Depreciation and amortization                          495,420         446,858
         Changes in operating assets and liabilities:
            (Increase) in accounts receivable               ( 1,183,919)    ( 1,839,900)
            (Increase) in inventories                       ( 1,609,951)    (   662,688)
            (Increase) in prepaid expenses                  (    87,335)    (    64,532)
            Increase in accounts payable,
              Accrued expenses, and other                       954,876         510,391
                                                            ------------    ------------
         Net cash provided (used) by operating activities   ( 1,198,094)    ( 1,158,286)
                                                            ------------    ------------

Cash flows from financing activities:
      Net increases under line of credit                        500,000         584,140
      Repayments of advances to affiliates                      298,041         103,328
      Borrowings (reductions) of debts, net                 (   433,907)      3,129,895
      Common stock transactions                                  69,750          67,725
                                                            ------------    -----------
         Net cash provided by financing activities              433,884       3,885,088
                                                            ------------    -----------

Cash flows from investing activities:
      Increase in funds held in escrow for equipment
        purchases                                                -          ( 2,150,816)
      Purchase of property, plant and equipment, net        (   138,595)    (   395,010)
                                                            ------------    ------------
         Net cash used by investing activities              (   138,595)    ( 2,545,826)
                                                            ------------    ------------

      Increase (decrease) in cash prior to effect of
         Foreign currency translation                       (   902,805)        180,976
      Effect of foreign currency translation on cash             49,004     (    31,099)
                                                            ------------    ------------

      Net increase (decrease) in cash                       (   853,801)        149,877

      Cash at beginning of period                             1,093,826          82,000
                                                            ------------    -----------

      Cash at end of period                                 $   240,025     $   231,877
                                                            ============    ===========

Supplemental Information:
      Cash used during the periods for payment of:
      Interest                                              $   218,333     $   265,431
                                                            ===========     ===========

      Income taxes                                          $      -        $     -
                                                            ===========     ===========



</TABLE>




The Company had no cash equivalents at September 30, 2003 or 2002


                                        6


<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
            NOTES TO THE CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

     The  information  contained in this Report is  unaudited,  but reflects all
adjustments  which are,  in the  opinion  of  management,  necessary  for a fair
statement of results of the interim periods, consisting only of normal recurring
accruals. The results for such interim periods are not necessarily indicative of
results to be expected for the full year.

Certain financial statement items for the three and nine months ended September
30, 2002 have been reclassified in order to conform with the 2003 presentation.

ITEM 2      MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
            RESULTS OF OPERATIONS

Liquidity and Capital Resources

     The primary sources of the Registrant's liquidity are its operations, short
term  borrowings  from a commercial  bank pursuant to a revolving line of credit
arrangement,  and  other  borrowings.  The total  borrowings  under the line are
secured by trade receivables and inventories, and can aggregate a maximum amount
of $5,500,000.  Borrowings under the line are due on demand from the bank. Under
the terms of the line,  the  Registrant  is  required  to  comply  with  certain
financial  covenants  related to its working capital  levels,  a maximum debt to
tangible  net worth  ratio,  and minimum debt  service  coverage  factor.  As of
September  30,  2003,  the amount  outstanding  pursuant  to this  facility  was
$4,750,000.

     During July,  2002,  the Registrant  finalized the working  capital line of
credit  discussed in the preceding  paragraph as well as an  Industrial  Revenue
Bond  financing  issued  through  the city of  Montgomery,  AL in the  amount of
$3,500,000  to be  utilized  for a  plant  expansion  and  related  purchase  of
equipment at the  Registrant's  Montgomery,  AL  facility.  Such  financing  was
secured with favorable interest rate terms which float with current  conditions.
The present interest rate is approximately 2% per year.

     The  Registrant  is involved in making  sales in the  Canadian  market and,
accordingly, is subject to fluctuations of the Canadian currency. The Registrant
does not engage in currency hedging and deals with such risk as a pricing issue.

    Results of operations for the three month periods July 1 - September 30:

     Net sales  decreased  approximately  6% or  approximately  $415,000 for the
quarter  ended  September  30,  2003 when  compared  to the same  quarter of the
preceding  year.  This was  primarily  due to decreased  sales of the  Company's
marine  anti-freeze  and  automotive  products.  The  anti-freeze  decrease  was
attributed to commodity pricing of raw materials and related freight issues, and
the automotive decrease resulted from initial customer reaction to the Company's
strategic decision to achieve higher margins on these products.

     Gross margins  improved and cost of goods sold decreased as a percentage of
net sales when  comparing the quarters  ended  September 30, 2003 and 2002.  The
percentages were 73% and 80% for the periods during 2003 and 2002, respectively.
This change was  primarily  due to  management's  on-going  initiatives  towards
improving   operating   margins   including  a  general  sales  price  increase,
utilization  of cash  discounts  offered by  suppliers,  and product  pricing in
response to current commodity costs.

     Advertising and promotion increased approximately $140,000 or 81% comparing
the three months ended  September  30, 2003 and 2002.  This was primarily due to
increased  co-operative  advertising programs and other planned increases in the
advertising budget.




                                        7


<PAGE>


     Selling and administrative  expenses increased  approximately $35,500 or 5%
when comparing the quarters ended  September 30, 2003 and 2002. Such changes are
attributable to normal incremental costs of operations.

     Interest expense,  which aggregated  approximately  $70,600 for the current
three month period, decreased approximately $24,600 when comparing the September
30,  2003  quarter  to the  corresponding  period  in 2002.  Such  decrease  was
primarily attributed to the current economic environment of low interest rates.


   Results of operations for the nine month periods January 1 - September 30:

     Net sales  decreased 4% or  approximately  $616,200 when comparing the nine
month periods of 2003 and 2002. This was primarily due to a decrease in sales of
the Company's  marine  anti-freeze  and  automotive  products.  The  anti-freeze
decrease  was  attributed  to  commodity  pricing of raw  materials  and related
freight  issues,  and the  automotive  decrease  resulted from initial  customer
reaction to the Company's  strategic decision to achieve higher margins on these
products.

     Gross margins  improved and cost of goods sold decreased as a percentage of
net sales when  comparing the nine month  periods  ended  September 30, 2003 and
2002.  The  percentages  were 75% and 76% for the periods  during 2003 and 2002,
respectively.  This change was impacted by cost increases experienced during the
earlier quarters of 2003 and management's on-going initiatives towards improving
operating margins including a general sales price increase,  utilization of cash
discounts  offered by  suppliers,  and  product  pricing in  response to current
commodity costs.

     Advertising and promotion  expenses  increased  approximately  $86,700 when
comparing  the nine months  ended  September  30, 2003 to the nine months  ended
September 30, 2002. This was primarily due to increased co-operative advertising
programs and other planned increases in the advertising budget.

     Selling and  administrative  expenses  increased  for the nine months ended
September  30, 2003 by  approximately  $301,300 or 15% when compared to the nine
months ended  September  30,  2002.  Such change was  attributable  to increased
personnel costs and other incremental costs of operations.

     Interest  expense  decreased  during  the  nine  month  period  in  2003 by
approximately  $47,000  when  compared  to the nine month  period of 2002.  Such
decrease was primarily  attributed to the current  economic  environment  of low
interest rates.


                           Forward-looking Statements:

     Certain   statements   contained  herein,   including  without   limitation
expectations   as  to   future   sales   and   operating   results,   constitute
forward-looking statements pursuant to the safe harbor provisions of the Private
Securities  Litigations  Reform Act of 1995.  For this purpose,  any  statements
contained  in this  report that are not  statements  of  historical  fact may be
deemed  forward-looking  statements.  Without  limiting  the  generality  of the
foregoing,  words  such as  "may",  "will",  "expect",  "anticipate",  "intend",
"could" or the negative other variations  thereof or comparable  terminology are
intended to identify forward-looking statements.  These statements involve known
and  unknown  risks,  uncertainties  and other  factors  which may cause  actual
results,  performance or achievements of the Company to be materially  different
from any future  results,  performance or  achievements  expressed or implied by
such forward-looking statements.  Factors which may affect the Company's results
include,  but are not limited to, the highly competitive nature of the Company's
industry;  reliance  on  certain  key  customers;  consumer  demand  for  marine
recreational  vehicle  and  automotive  products;  advertising  and  promotional
efforts,  and other  factors.  The Company will not undertake  and  specifically
declines any obligation to update or correct any  forward-looking  statements to
reflect events or circumstances  after the date of such statements or to reflect
the occurrence of anticipated or unanticipated events.

                                        8


<PAGE>


                           PART II - OTHER INFORMATION

Item 1 - Legal Proceedings: See the Registrant's Form 10-K for the year ended
         December 31, 2002.

Item 2 - Changes in Securities:  Not Applicable

Item 3 - Defaults Upon Senior Securities:  Not Applicable

Item 4 - Submission of Matters to Vote of Security Holders:  Not Applicable

Item 5 - Other Information:  Not Applicable

Item 6 - Exhibits:  Not Applicable

(A)      Exhibits:  Not Applicable

(B)      Reports on Form 8-K: Not Applicable






                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant has duly caused this report to be signed on behalf by the Undersigned
there unto duly authorized.

   OCEAN BIO-CHEM, INC.

Date: November 12, 2003                       /s/ Peter G. Dornau
     ----------------------------------      ------------------------------
                                             Peter G. Dornau
                                             Chairman of the Board of Directors
                                             and Chief Executive Officer


                                             /s/ Edward Anchel
                                             -------------------------------
                                             Edward Anchel
                                             Chief Financial Officer













                                        9


<PAGE>
                                                            Exhibit 31

                                 CERTIFICATION


I, Peter G. Dornau certify that:

     1. I have reviewed this  quarterly  report on Form 10-Q of Ocean  Bio-Chem,
Inc.:

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report:

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the  financial  condition,  results of operation  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

     4. The  registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a - 14 and 15d - 14) for the registrant and we have:

     i.  Designed such  disclosure  controls and  procedures to ensure  material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others  within those  entities,  particularly  during the
period in which this quarterly report is being prepared;

     ii. Evaluated the effectiveness of the registrant's disclosure controls and
procedures  as of a date  within  90  days  prior  to the  filing  date  of this
quarterly report (the "Evaluation Date"); and

     iii.   Presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness of the disclosure controls and procedures based on our evaluations
as of the Evaluation Date;

     5. The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
or  registrant's  board of  directors  (or  persons  performing  the  equivalent
function):


     i. All  significant  deficiencies  in the design or  operation  of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and have  identified  for the
registrant's auditors any material weakness in internal controls; and

     ii. Any fraud,  whether or not material,  that involves management or other
employees who have a significant role in the registrant's internal controls; and

     6. The registrant's  other certifying  officer and I have indicated in this
quarterly  report  whether or not there  were  significant  changes in  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of or most recent  evaluation,  including any  corrective
actions with regard to significant deficiencies and material weaknesses.

     OCEAN BIO-CHEM, INC.

           Date:    November 12, 2003                  /s/ Peter G. Dornau
                    -------------------                ----------------------
                                                       Peter D. Dornau
                                                       Chairman of the Board and
                                                       Chief Executive Officer


<PAGE>
                                                            Exhibit 31.1

                                 CERTIFICATION


I, Edward Anchel, certify that:

     1. I have reviewed this  quarterly  report on Form 10-Q of Ocean  Bio-Chem,
Inc.:

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report:

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the  financial  condition,  results of operation  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

     4. The  registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a - 14 and 15d - 14) for the registrant and we have:

     i.  Designed such  disclosure  controls and  procedures to ensure  material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others  within those  entities,  particularly  during the
period in which this quarterly report is being prepared;

     ii. Evaluated the effectiveness of the registrant's disclosure controls and
procedures  as of a date  within  90  days  prior  to the  filing  date  of this
quarterly report (the "Evaluation Date"); and

     iii.   Presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness of the disclosure controls and procedures based on our evaluations
as of the Evaluation Date;

     5. The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
or  registrant's  board of  directors  (or  persons  performing  the  equivalent
function):


     i. All  significant  deficiencies  in the design or  operation  of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and have  identified  for the
registrant's auditors any material weakness in internal controls; and

     ii. Any fraud,  whether or not material,  that involves management or other
employees who have a significant role in the registrant's internal controls; and

     6. The registrant's  other certifying  officer and I have indicated in this
quarterly  report  whether or not there  were  significant  changes in  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of or most recent  evaluation,  including any  corrective
actions with regard to significant deficiencies and material weaknesses.

     OCEAN BIO-CHEM, INC.

           Date:    November 12, 2003                  /s/ Edward Anchel
                    -------------------                ----------------------
                                                       Edward Anchel
                                                       Chief Financial Officer
<PAGE>



                                                            Exhibit 32
                                 CERTIFICATION

     Pursuant  to  18U.S.C.Section  1350,  the  undersigned  officers  of  Ocean
Bio-Chem,  Inc. (the  "Company"),  hereby  certify that the Company's  Quarterly
Report on Form 10-Q for the quarter  ended  September  30,  2003 (the  "Report")
fully complies with the  requirements  of Section 13(a) or 15(d), as applicable,
of the Securities Exchange Act of 1934 and that the information contained in the
Report fairly presents,  in all material respects,  the financial  condition and
results of operation of the Company.

Dated: November 12, 2003


                                                       /s/ Peter G. Dornau
                                                       ------------------------
                                                       Peter G. Dornau
                                                       Chairman of the Board of
                                                       Directors  and Chief
                                                       Executive Office




                                                       /s/ Edward Anchel
                                                       ------------------------
                                                       Edward Anchel
                                                       Chief Financial Officer